Extracorporeal photopheresis for the treatment of chronic graft versus host disease
E Kansu, D Ward, AP Sanchez, R Cunard, M Hayran… - …, 2022 - Taylor & Francis
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: prospective single‐center study
I Sakellari, E Gavriilaki, I Batsis… - Journal of Clinical …, 2018 - Wiley Online Library
Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …
Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host …
M Nygaard, T Karlsmark, NS Andersen… - Bone Marrow …, 2019 - nature.com
Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …
Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: a retrospective multicenter study
MS Dal, H Batgi, MA Erkurt, IY Hindilerden… - … and Apheresis Science, 2021 - Elsevier
Background and objectives Extracorporeal photopheresis (ECP) is a treatment strategy in
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …
[HTML][HTML] Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis …
HT Greinix, K van Besien, AH Elmaagacli… - Biology of Blood and …, 2011 - Elsevier
In a prior multicenter randomized controlled trial, we found that a 12-week course of
extracorporeal photopheresis (ECP) plus standard immunosuppressive therapy resulted in …
extracorporeal photopheresis (ECP) plus standard immunosuppressive therapy resulted in …
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
MED Flowers, JF Apperley… - Blood, The Journal …, 2008 - ashpublications.org
Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …
Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology
P Tsirigotis, P Kaloyannidis, A Papalexandri… - … and Apheresis Science, 2012 - Elsevier
The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …
Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)
FJ Child, R Ratnavel, P Watkins, D Samson… - Bone marrow …, 1999 - nature.com
The aim of our study was to assess the efficacy of extracorporeal photopheresis (ECP) in
chronic graft-versus-host disease (GVHD). Eleven patients with chronic cutaneous GVHD …
chronic graft-versus-host disease (GVHD). Eleven patients with chronic cutaneous GVHD …
Extracorporeal photochemotherapy for the treatment of chronic graft‐versus‐host disease: trend for a possible cell dose‐related effect?
Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …
The role of extracorporeal photopheresis in chronic graft-versus-host disease
V Radojcic, MA Pletneva, DR Couriel - Transfusion and Apheresis Science, 2015 - Elsevier
Chronic graft-versus-host disease (GVHD) is the most important cause of late morbidity and
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …